Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of Circulating Tumour DNA in Risk Stratification in Melanoma

NCT07531121 is registered in ClinicalTrials.gov with Herlev and Gentofte Hospital as lead sponsor.

NCT NCT07531121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07531121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of Circulating Tumour DNA in Risk Stratification in Melanoma
Lead sponsor
Herlev and Gentofte Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
September 10, 2021
Completion date
May 3, 2026
Enrollment
296 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin cancer)